Published: Jun 30, 2026
Updated: Jun 30, 2026

Bone marrow transplants (BMT), also known as hematopoietic stem cell transplants (HSCT), can be life-saving for patients whose bone marrow is not functioning to produce healthy blood cells. This procedure is used to treat both blood-related cancers and non-cancer blood-related disorders, immune deficiencies, and certain genetic conditions (inherited).
Many patients wish to know whether they are candidates for BMTs or whether their loved ones are. Knowing the signs of medical conditions and what is required for eligibility will help you receive the treatment you need for the best long-term results.
Bone marrow, a soft, spongy tissue inside the bones, produces red blood cells (RBCs), white blood cells (WBCs), and platelets. When bone marrow becomes diseased or is poorly functioning, it can dramatically affect the ability to fight off infections, carry oxygen, and control bleeding.
A donor BMT replaces damaged or poorly functioning stem cells with healthy stem cells taken either from the patient (autologous transplant) or from an acceptable donor (allogeneic transplant). These new stem cells will eventually rebuild healthy bone marrow and restore normal production of RBCs, WBCs, and platelets.
Not everyone with blood disorders can get a transplant. Doctors will give the patient a bone marrow transplant when all other treatment options do not work, or they are at very high risk of relapsing into that disease.
Some examples of patients who can benefit from a transplant are:
The decision is based on disease severity, overall health, age, previous treatments, and donor availability.
Leukemia is among the most frequent causes for performing bone-marrow transplants. The condition develops due to the uncontrolled proliferation of abnormal white blood cells, reducing the body's ability to produce red and/or white blood cells.
Patients diagnosed with the following types of leukaemia might be advised to have a transplant:
Usually, after chemotherapy, the transplant replaces damaged(sick) Bone Marrow with healthy stem cells; this reduces the chances of the disease returning.
Lymphoma Patients diagnosed with Hodgkin Lymphoma or Non-Hodgkin Lymphoma may need to undergo a transplant if:
Commonly, patients with relapsed lymphoma receive Autologous Transplants; however, in certain cases, Allogeneic Transplants may be performed.
Multiple myeloma is a disease that affects the plasma cells in the bone marrow. Although multiple myeloma is generally considered an incurable disease, autologous stem cell transplantation can significantly help control disease progression, prolong remission, and improve quality of life.
Aplastic Anemia (aka Bone Marrow Failure Syndrome). A diagnosis of aplastic anemia occurs when a patient does not produce enough blood cells due to failure of the bone marrow. Patients will typically experience severe fatigue, frequent infections, and uncontrolled bleeding.
Patients who are younger and have a compatible donor may have the best chance of achieving a long-term cure through the procedure of bone marrow transplant.
MDS is characterised by impaired production (cell maturation) of blood cells, as well as the potential to transform into acute leukemia. For patients with high-risk MDS, the only potentially curative option is transplantation.
Children born with severe thalassemia are dependent on life-long blood transfusions and the use of iron chelation therapy. If children receive a bone marrow transplant performed at an early age, they can potentially be cured completely, thus avoiding the need for frequent blood transfusions.
Patients who have severe sickle cell disease tend to have repeated episodes of severe pain, suffer from acute stroke, experience organ damage due to repeated painful events, and are typically anemic on a long-term basis.
There is an increasing trend to recommend bone marrow transplant for carefully selected patients, especially children who have matched sibling donors.
Some inherited diseases of the immune system prevent an individual from adequately fighting off infection.
Conditions that may require transplantation include:
Performing a transplant early in the course of the disease will restore effective immunity and greatly improve life expectancy.
Category | Conditions | Why a Bone Marrow Transplant May Be Needed |
Blood Cancers | Leukemia, Lymphoma, Multiple Myeloma | To replace diseased bone marrow after high-dose chemotherapy or radiation and restore healthy blood cell production. |
Bone Marrow Failure Disorders | Aplastic Anemia, Myelodysplastic Syndromes (MDS) | When the bone marrow cannot produce enough healthy red blood cells, white blood cells, or platelets. |
Inherited Blood Disorders | Thalassemia, Sickle Cell Disease | To replace defective stem cells with healthy ones and potentially provide a long-term cure. |
Inherited Immune System Disorders | Severe Combined Immunodeficiency (SCID), Wiskott-Aldrich Syndrome | To rebuild a healthy immune system capable of fighting infections effectively. |
Rare Genetic & Metabolic Disorders | Hurler Syndrome, Adrenoleukodystrophy (ALD), Krabbe Disease | To provide healthy donor cells that produce missing enzymes or slow disease progression. |
Relapsed or High-Risk Disease | Recurrent leukemia, aggressive lymphoma, and refractory multiple myeloma | When the disease returns after treatment or does not respond adequately to standard therapies. |
Patients Requiring Intensive Cancer Therapy | Selected solid tumors and hematologic malignancies | To restore bone marrow function after very high-dose chemotherapy that would otherwise permanently damage it. |
The decision to undergo a transplant procedure depends on whether a person qualifies as a candidate for transplantation. Only a doctor will make this determination, but the following signs and symptoms may be reasons to consider further evaluation:
If someone has one or more of these symptoms, they may have a serious blood disorder that may require more advanced treatment than what has previously been provided by a physician.
Bone marrow transplantation is a complex process, and not all patients meet the criteria to be considered good candidates. A physician will take the following into consideration before recommending a transplant:
The wide range of tests performed will help ensure that all benefits of receiving a transplant far outweigh the risks associated with having the transplant.
The availability of bone marrow transplantation has changed the landscape for treating patients with life-threatening blood disorders and cancers. Significant advances in donor matching, supportive care, infection control, and transplant techniques have greatly improved patient outcomes in the past few years.
The process is very complex, yet it provides patients with an appropriate diagnosis and an opportunity for long-term remission or potential cure. If you were diagnosed with any of these blood disorders and would like to get more information about whether or not a transplantation would be appropriate for your specific case. The patient will be evaluated for their transplant options at your earliest convenience to determine whether or not they are possible. Early intervention can increase your chances of success and help you live a longer, healthier life.

Tanya Bose is a medical content specialist with a strong medical background. She has completed her Bachelor's and Master’s in Biotechnology from Amity University. With a deep understanding of biomedical sciences and research, she develops authoritative and patient-focused medical content covering treatments, surgical procedures, and healthcare innovations. Her writing emphasizes accuracy, clarity, and evidence-based information to help readers better understand complex medical topics. She is dedicated to improving patient awareness and supporting informed healthcare decisions by delivering trustworthy medical insights in a clear and accessible format.

Dr. Akash Khandelwal is a distinguished Haematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey